The Nuclear Receptor Nr4a1 Acts as a Microglia Rheostat and Serves as a Therapeutic Target in Autoimmune-Driven Central Nervous System Inflammation

MLA

Georg Schett, et al. “The Nuclear Receptor Nr4a1 Acts as a Microglia Rheostat and Serves as a Therapeutic Target in Autoimmune-Driven Central Nervous System Inflammation.” The Journal of Immunology, Jan. 2017. EBSCOhost, https://doi.org/10.4049/jimmunol.1600638.

APA

Georg Schett, Gerhard Krönke, Tobias Rothe, Beate Winner, Daniel Metzger, Francesc Pérez-Brangulí, Hiroshi Ichinose, Maria Faas, Natacha Ipseiz, & Stefanie C. Lang. (2017). The Nuclear Receptor Nr4a1 Acts as a Microglia Rheostat and Serves as a Therapeutic Target in Autoimmune-Driven Central Nervous System Inflammation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.1600638

Chicago

Georg Schett, Gerhard Krönke, Tobias Rothe, Beate Winner, Daniel Metzger, Francesc Pérez-Brangulí, Hiroshi Ichinose, Maria Faas, Natacha Ipseiz, and Stefanie C. Lang. 2017. “The Nuclear Receptor Nr4a1 Acts as a Microglia Rheostat and Serves as a Therapeutic Target in Autoimmune-Driven Central Nervous System Inflammation.” The Journal of Immunology, January. doi:10.4049/jimmunol.1600638.